MARKER THERAPEUTICS, INC. Current Liabilities
MARKER THERAPEUTICS, INC. (MRKR) had Current Liabilities of $2.42 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-14
- 2026-06-30: Liabilities, Current $2.42M.
- 2026-03-31: Liabilities, Current $3.64M.
- 2025-12-31: Liabilities, Current $2.27M.
- 2025-09-30: Liabilities, Current $3.35M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $2.42M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $3.64M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $2.27M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $3.35M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $4.28M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $2.50M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $3.46M 10-K · filed 2026-03-18 | |
| 2024-09-30 | $3.46M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $1.97M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $2.30M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $3.07M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $2.78M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $2.92M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $5.20M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $7.78M 10-K · filed 2024-03-26 | |
| 2022-09-30 | $11.29M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $13.47M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $8.21M 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $12.90M 10-K · filed 2023-03-22 | |
| 2021-09-30 | $8.23M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $5.66M 10-Q · filed 2021-08-10 | |
| 2021-03-31 | $4.15M 10-Q · filed 2021-05-12 | |
| 2020-12-31 | $6.40M 10-K · filed 2022-03-17 | |
| 2020-09-30 | $6.02M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $4.98M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $3.16M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $1.99M 10-K · filed 2021-03-09 | |
| 2019-09-30 | $3.19M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $3.21M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $2.94M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $2.80M 10-K · filed 2020-03-12 | |
| 2018-09-30 | $3.70M 10-Q · filed 2018-11-13 | |
| 2018-06-30 | $3.75M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $2.31M 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $1.52M 10-K · filed 2019-03-15 | |
| 2017-09-30 | $1.77M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $1.58M 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $1.96M 10-Q · filed 2017-05-05 | |
| 2016-12-31 | $1.74M 10-K · filed 2018-03-23 | |
| 2016-09-30 | $2.20M 10-Q · filed 2016-11-04 | |
| 2016-06-30 | $23.12M 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $31.46M 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $28.01M 10-K · filed 2017-03-14 | |
| 2015-09-30 | $33.62M 10-Q/A · filed 2016-04-14 | $8.85M 10-Q · filed 2015-11-16 |
| 2015-06-30 | $71.35M 10-Q/A · filed 2016-04-14 | $13.06M 10-Q · filed 2015-08-14 |
| 2015-03-31 | $10.24M 10-Q/A · filed 2016-04-14 | $3.30M 10-Q · filed 2015-05-15 |
| 2014-12-31 | $1.25M 10-Q/A · filed 2016-04-14 | |
| 2014-09-30 | $1.30M 10-Q · filed 2014-11-19 | |
| 2014-06-30 | $2.60M 10-Q · filed 2014-08-18 | |
| 2014-03-31 | $5.61M 10-Q/A · filed 2014-05-21 | |
| 2013-12-31 | $8.85M 10-K · filed 2015-04-15 | |
| 2013-09-30 | $5.25M 10-Q · filed 2013-11-19 | |
| 2013-03-31 | $5.64M 10-Q/A · filed 2013-08-19 | |
| 2012-12-31 | $6.13M 10-K/A · filed 2014-04-17 | $5.77M 10-K · filed 2013-05-15 |
| 2012-09-30 | $4.43M 10-Q · filed 2012-11-19 | |
| 2012-06-30 | $3.76M 10-Q/A · filed 2012-09-12 | |
| 2012-03-31 | $3.70M 10-Q · filed 2012-05-21 | |
| 2011-12-31 | $3.80M 10-K · filed 2013-05-15 | |
| 2011-09-30 | $1.71M 10-Q · filed 2011-11-21 | |
| 2011-06-30 | $1.37M 10-Q · filed 2011-08-22 | |
| 2010-12-31 | $3.98M 10-K · filed 2012-04-16 | $3.39M 10-Q · filed 2011-08-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |